FDMT CapEx to Revenue

4D Molecular Therapeutics Inc · CapEx to Revenue

FDMT logo

FDMT CapEx to Revenue

Current (TTM)0.65%
FDMT CapEx/Revenue (9.90% → 0.65%)
High-resolution chart · PNG

FDMT capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.629%
10,232.4324%
13.3716%
368.6801%
50.5045%
7.3465%
45.8488%
2.9299%
9.8964%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.